SCHEMBL7779761

SCHEMBL7779761

NS(=O)(=O)c1ccc(-c2n[nH]c(C(F)(F)F)c2-c2ccccn2)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LRRK2 Q5S007 3/20 0.60
PTGS2 P35354 2/20 0.47
PTGS1 P23219 1/20 0.47
CA2 P00918 6/20 0.46
CA9 Q16790 6/20 0.46
CA1 P00915 5/20 0.46
CA12 O43570 4/20 0.46
MAP2K7 O14733 1/20 0.43
MAP2K4 P45985 1/20 0.43
TTK P33981 1/20 0.42
ABCC8 Q09428 1/20 0.41
KCNJ11 Q14654 1/20 0.41
GYS1 P13807 2/20 0.41
MEN1 O00255 1/20 0.41
MAPT P10636 1/20 0.41
CNR1 P21554 1/20 0.41
NR2F2 P24468 1/20 0.41
CNR2 P34972 1/20 0.41
KMT2A Q03164 1/20 0.41
GPR55 Q9Y2T6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7780547 0.88 LRRK2 (0.49) LRRK2PTGS2PTGS1ABCC8KCNJ11
SCHEMBL7773326 0.88 LRRK2 (0.68) LRRK2PTGS2PTGS1CA2CA9
SCHEMBL7773215 0.84 LRRK2 (0.77) LRRK2PTGS2CA2CA1MAP2K7
SCHEMBL7773014 0.83 LRRK2 (0.61) LRRK2PTGS2PTGS1CA2CA9
SCHEMBL7778234 0.82 LRRK2 (0.65) LRRK2PTGS2PTGS1CA2CA9
SCHEMBL7779654 0.81 LRRK2 (0.60) LRRK2PTGS2PTGS1CA2CA9
SCHEMBL7779954 0.81 LRRK2 (0.60) LRRK2PTGS2PTGS1CA2CA9
SCHEMBL7777620 0.81 LRRK2 (0.60) LRRK2PTGS2PTGS1CA2CA9
SCHEMBL7780666 0.81 LRRK2 (0.54) LRRK2PTGS2PTGS1MAP2K7MAP2K4
SCHEMBL8627852 0.81 LRRK2 (0.44) LRRK2PTGS2PTGS1CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP claimed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP claimed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US claimed
EP-0772597-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1997-05-14 EP claimed
WO-1996003385-A1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION G.D. SEARLE & CO. (US) 1996-02-08 WO claimed
EP-0772597-B1 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION SEARLE & CO (US) 2001-12-12 EP disclosed
EP-1127878-A1 3,4 - substituted pyrazoles for the treatment of inflammation G.D. SEARLE & CO. (US) 2001-08-29 EP disclosed
US-6028072-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 2000-02-22 US disclosed
US-5580985-A ANTIARTHRITIC AGENT; SIDE EFFECT REDUCTION G. D. SEARLE & CO. (US) 1996-12-03 US disclosed
US-5486534-A 3,4-substituted pyrazoles for the treatment of inflammation G. D. SEARLE & CO. (US) 1996-01-23 US disclosed